Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hilgard

Showing results (51-60 of 135) with videos related to

Pageof 14
Sort By:
Investigational New Drugs|January 1, 1984
Antineoplastic activity of ASTA Z 7557 (NSC-345842, INN mafosfamide) on transplantable murine tumorsG Atassi, P Hilgard, J Pohl
Arzneimittel-Forschung|July 1, 1989
The tetrazolium dye assay for rapid in vitro assessment of cytotoxicityM Iselt, W Holtei, P Hilgard
Thrombosis Research|July 1, 1975
Induction of disseminated intravascular coagulation by endotoxin and saline loading in rats. I. The influence on fibrinogen turnover and plasma parametersH Heyes, P Hilgard, W Theiss
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Opposite effect of miltefosine on the antineoplastic activity and haematological toxicity of cyclophosphamideJ Stekar, P Hilgard, T Klenner
Cancer Treatment Reviews|September 1, 1983
Ifosfamide--current aspects and perspectivesP Hilgard, K Herdrich, W Brade
Journal of Cancer Research and Clinical Oncology|January 1, 1997
The development of alkylphosphocholines as signal transduction inhibitors: experimental and clinical challengesP Hilgard, J Pohl, J Engel
Deutsche Medizinische Wochenschrift (1946)|February 9, 1973
[Factor XII deficiency in two brothers]G Müller, P Hilgard, V Hiemeyer
Thrombosis Research|June 1, 1982
Heparin treatment of microangiopathic haemolytic anaemia associated with an experimental tumourH Heyes, W Köhle, P Hilgard
Cardiovascular Research|September 1, 1975
Pulmonary vasoconstriction produced by protamine and protamine-heparin complex in the isolated cat lung perfused with blood or dextranJ Jastrzebski, P Hilgard, M K Sykes
Diabetologia|March 1, 1980
Platelet shape change abnormalities in diabetic retinopathyM Porta, P Hilgard, E M Kohner
Pageof 14

Showing results (51-60 of 135) with videos related to

Sort By:
Pageof 14
Investigational New Drugs|January 1, 1984
Antineoplastic activity of ASTA Z 7557 (NSC-345842, INN mafosfamide) on transplantable murine tumorsG Atassi, P Hilgard, J Pohl
Arzneimittel-Forschung|July 1, 1989
The tetrazolium dye assay for rapid in vitro assessment of cytotoxicityM Iselt, W Holtei, P Hilgard
Thrombosis Research|July 1, 1975
Induction of disseminated intravascular coagulation by endotoxin and saline loading in rats. I. The influence on fibrinogen turnover and plasma parametersH Heyes, P Hilgard, W Theiss
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Opposite effect of miltefosine on the antineoplastic activity and haematological toxicity of cyclophosphamideJ Stekar, P Hilgard, T Klenner
Cancer Treatment Reviews|September 1, 1983
Ifosfamide--current aspects and perspectivesP Hilgard, K Herdrich, W Brade
Journal of Cancer Research and Clinical Oncology|January 1, 1997
The development of alkylphosphocholines as signal transduction inhibitors: experimental and clinical challengesP Hilgard, J Pohl, J Engel
Deutsche Medizinische Wochenschrift (1946)|February 9, 1973
[Factor XII deficiency in two brothers]G Müller, P Hilgard, V Hiemeyer
Thrombosis Research|June 1, 1982
Heparin treatment of microangiopathic haemolytic anaemia associated with an experimental tumourH Heyes, W Köhle, P Hilgard
Cardiovascular Research|September 1, 1975
Pulmonary vasoconstriction produced by protamine and protamine-heparin complex in the isolated cat lung perfused with blood or dextranJ Jastrzebski, P Hilgard, M K Sykes
Diabetologia|March 1, 1980
Platelet shape change abnormalities in diabetic retinopathyM Porta, P Hilgard, E M Kohner
Pageof 14